Wikipedia

Mga baryante ng SARS-CoV-2

Ang Mga baryante ng SARS-CoV-2 ay ang mga baryante ng SARS-CoV-2 na nagsanhi ng pandemya sa mundo bunsod ng COVID-19, bawat bansa ay nakitaan ng mutution mula sa mga strain ng SARS-CoV-2 na nag mula sa Wuhan, Hubei, Tsina noong Disyembre 1, 2019. Ang mga baryante ng SARS-CoV-2 ay ang mga sanga'ng anak dahil sa pag mutate ng birus, ang iba't ibang baryante ay mayroong kakayahang kumopya ng kawangis upang magparami, mayroong mga baryante ay nagkakamali ng pagkopya mula sa strain na ito o tinatawag na "error spelled". ito ay hindi na maaring magpakalat ng baryant.

Ang SARS-CoV-2 baryants na nagsasanhi ng COVID-19 sa mundo sa kasalukuyan
Positive, negative, and neutral mutations during the evolution of coronaviruses like SARS-CoV-2.

Talahanayan ng Pangkalahatang ideya

baguhin
5 Variant of concern

 A  Alpha
 B  Beta
 G  Gamma
 D  Delta
 O  Omicron

Unang deteksyon PANGOLIN nomenclature Ibang pangalan Notable mutations Evidence of clinical changes[note 1] Pagkalat Sang.
  United Kingdom 2020 Pebrero[1] Global B.1.1.7 20I/501Y.V1 VOC-20DEC-01[A] — N501Y, 69–70del, P681H[2][3] Padron:Estimate higher[4] Padron:Estimate more lethal[5][B] No change[7]
  Nigeria 2020 Agosto[8] Global B.1.1.207 — — — P681H[2] No evidence of change[9] No evidence of change[9] Under investigation
  United States 2020 Hunyo[10] Global B.1.429, B.1.427[11] 20C/S:452R — CAL.20C[12] I4205V, D1183Y, S13I, W152C, L452R Padron:Estimate (18.6%–24.2%) higher[13][14] Under investigation Moderate-to-severe reduction in neutralisation[15]
  South Africa 2020 Oktubre[2] Global B.1.351 20H/501Y.V2 VOC-20DEC-02 501Y.V2[7] N501Y, K417N, E484K[2] Padron:Estimate higher[7] No evidence of change[9] Significant reduction in neutralisation by antibodies[16][17]
  India 2020 Oktubre[18] Global B.1.617 — VUI-21APR-01[19] — E484Q, L452R, P681R[20] Under investigation Under investigation Slight reduction in effective neutralisation[21]
  Japan
  Brazil 		2020 Disyembre[22] Global P.1 20J/501Y.V3 VOC-21JAN-02 B.1.1.28.1[23][11] N501Y, E484K, K417T[2] Padron:Estimate higher[24][C][better source needed] Padron:Estimate more lethal[25][D] Overall reduction in effective neutralisation[7]
  United Kingdom
  Nigeria 		2020 Disyembre[26] Global B.1.525 20C[E] VUI-21FEB-03[F]
E484K, F888L[27] Under investigation Under investigation Possibly reduced neutralisation[13]
  India 2021 Octubre Global AY.4.2
  1. ↑ B.1.1.7 with E484K is separately designated VOC-21FEB-02
  2. ↑ Another study[6] has estimated that B.1.1.7 may be 32–104% more lethal
  3. ↑ Another preliminary study[25] has estimated that P.1 may be 170–240% more transmissible, with a credible interval with a low probability of 50%.
  4. ↑ The reported credible interval has a low probability of only 50%, so the estimated lethality can only be understood as possible, not certain nor likely.
  5. ↑ Includes B.1.525 and B.1.526.[13]
  6. ↑ Formerly UK1188.

Kilalang baryante

baguhin
Karagdagang impormasyon: SARS-CoV-2
Taon WHO Greek lebel Baryante Pamagat Pinagmulan
2019 2019-nCoV c SARSr-CoV   Pandemya ng COVID-19 (COVID-19) Wuhan, Tsina
2020 Alpha α SARS-CoV-2 Alpha variant Pagkalat ng B.1.1.7 ng 2020 (COVID-19) Kent, United Kingdom
Beta β SARS-CoV-2 Beta variant Pagkalat ng 501.V2 (COVID-19) Silangang Cape, Timog Aprika
2021 Gamma Γ SARS-CoV-2 Gamma variant Pagkalat ng Lineage P.1 (COVID-19) Manaus, Brazil
Delta Δ SARS-CoV-2 Delta variant Pagkalat ng B.1.617.2 (COVID-19) New Delhi, India
Delta δ SARS-CoV-2 Delta Plus variant Pagkalat ng B.1.617.2 (COVID-19) Nepal & Maharashtra, India
2020 Epsilon ε SARS-CoV-2 Epsilon variant Pagkalat ng CAL.20C (COVID-19) Los Angeles, California, USA
2021 Zeta ζ SARS-CoV-2 Zeta variant Pagkalat ng Lineage P.2 (COVID-19) Rio de Janeiro, Brazil
2020 Eta η SARS-CoV-2 Eta variant Pagkalat ng Lineage B.1.525 (COVID-19) Lagos, Nigeria
B.1.1.207 Lineage B.1.1.207 Pagkalat ng Lineage B.1.1.207 (COVID-19) Nigeria
ΔFVI SARS-CoV-2 Cluster 5 variant Pagkalat ng Cluster 5 (COVID-19) Hilagang Jutland, Denmark
2021 B.1.1.7 w/ E484K Lineage B.1.1.318 Pagkalat ng B.1.1.318 (COVID-19) United Kingdom
Theta Θ SARS-CoV-2 Theta variant Pagkalat ng Lineage P.3 (COVID-19) Cebu, Pilipinas
2020 Iota ι SARS-CoV-2 Iota variant Pagkalat ng B.1.526 (COVID-19) Lungsod ng Bagong York, USA
2021 Kappa κ SARS-CoV-2 Kappa variant Pagkalat ng Lineage B.1.617 (COVID-19) Delhi, India
Lambda Λ SARS-CoV-2 Lambda variant Pagkalat ng Lineage C.37 (COVID-19) Lima, Peru
Mu μ SARS-CoV-2 Mu variant Pagkalat ng Lineage B.1.621 (COVID-19) Colombia
C.1.2 SARS-CoV-2 Lineage C.1.2 Pagkalat ng Lineage C.1.2 (COVID-19) Timog Aprika
AY.4.2 SARS-CoV-2 Delta Subvariant Pagkalat ng Lineage AY.4.2 (COVID-19) India
Omicron O SARS-CoV-2 Omicron variant Pagkalat ng Lineage B.1.1.259 (COVID-19) Botswana
2022 IHU SARS-CoV-2 Ihu variant Pagkalat ng Lineage B.1.640.2 (COVID-19) Marseille, Pransya
BA.2 SARS-CoV-2 Omicron Subvariant Pagkalat ng Lineage BA.2 (COVID-19) Denmark, Europa
AY.4.2 SARS-CoV-2 Deltacron variant Pagkalat ng Deltacron (COVID-19) Cyprus
BA1 & BA.2 SARS-CoV-2 Xe variant Pagkalat ng XE variant (COVID-19) United Kingdom

Mga iba't ibang pag-aalala (WHO)

baguhin
Kategorya ng baryante


 3  Variant of concern
 2  Variant of interest
 1  Variant of old interest

​SARS-CoV-2 strain  
Alpha   Beta   Gamma   Delta   Delta + (aktibo)  
Delta Sub+   Epsilon   Zeta   Eta   Theta  
Iota   Kappa   Lambda   Mu   Nu (unused)
Xi (unused) Omicron  Pi Rho Sigma
Tau Upsilon Phi Chi Psi
Omega
Griyegong alpabeto

Mga ibang kilalang baryant

baguhin
R.1
Lineage B.1.1.207
Lineage B.1.620

Dinagdag na baryante

baguhin
  • Lineage B.1.618
  • Lineage B.1.1.318
  • Lineage B.1.1.317
  • Lineage C.1.2
  • Lineage B.1.640.2

Kilalang mutasyon

baguhin
  • N440K
  • L452R
  • S477G/N
  • E484Q
  • E484K
  • N501Y
  • D614G
  • P681H
  • P681R
  • A701V

Tingnan rin

baguhin

Sanggunian

baguhin
  1. ↑ Maling banggit (Hindi tamang <ref> tag; walang binigay na teksto para sa refs na may pangalang pango-lineages); $2
  2. ↑ 2.0 2.1 2.2 2.3 2.4 Maling banggit (Hindi tamang <ref> tag; walang binigay na teksto para sa refs na may pangalang :3); $2
  3. ↑ Chand et al. (2020), p. 6, Potential impact of spike variant N501Y.
  4. ↑ Padron:Cite techreport
  5. ↑ Davies G, Jarvis C, Edmunds WJ, Jewell N, Diaz-Ordaz K, Keogh R (2021-03-15). "Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7" (Published). doi:10.1038/s41586-021-03426-1. Nakuha noong 2021-04-29 – sa pamamagitan ni/ng Nature. {{cite journal}}: Cite journal requires |journal= (tulong)CS1 maint: date auto-translated (link)
  6. ↑ DChallen R, Brooks-Pollock E, Read J, Dyson L, Tsaneva-Atanasova K, Danon L (2021-03-10). "Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study" (Published). doi:10.1136/bmj.n579. Nakuha noong 2021-04-29 – sa pamamagitan ni/ng The BMJ. {{cite journal}}: Cite journal requires |journal= (tulong)CS1 maint: date auto-translated (link)
  7. ↑ 7.0 7.1 7.2 7.3 Padron:Cite techreport
  8. ↑ "Lineage B.1.1.207". cov-lineages.org. Pango team. Inarkibo mula sa orihinal noong 2021-01-27. Nakuha noong 2021-03-11.{{cite web}}: CS1 maint: date auto-translated (link) Graphic shows B.1.1.207 detected in Peru, Germany, Singapore, Hong Kong, Vietnam, Costa Rica, South Korea, Canada, Australia, Japan, France, Italy, Ecuador, Mexico, UK and the USA.
  9. ↑ 9.0 9.1 9.2 Sruthi S (2021-02-10). "Notable Variants And Mutation Of SARS-CoV-2". BioTecNika. Nakuha noong 2021-03-22.{{cite news}}: CS1 maint: date auto-translated (link)
  10. ↑ "Lineage B.1.429". cov-lineages.org. Pango team. Inarkibo mula sa orihinal noong 2021-04-28. Nakuha noong 2021-03-19.{{cite web}}: CS1 maint: date auto-translated (link) Graphic shows B.1.429 detected in the USA, Mexico, Canada, the UK, France, Denmark, Australia, Taiwan, Japan, South Korea, Australia, New Zealand, Guadeloupe, and Aruba.
  11. ↑ 11.0 11.1 Maling banggit (Hindi tamang <ref> tag; walang binigay na teksto para sa refs na may pangalang aci-variants); $2
  12. ↑ "Southern California COVID-19 Strain Rapidly Expands Global Reach". Cedars-Sinai Newsroom. Los Angeles. 2021-02-11. Nakuha noong 2021-03-17.{{cite news}}: CS1 maint: date auto-translated (link)
  13. ↑ 13.0 13.1 13.2 Maling banggit (Hindi tamang <ref> tag; walang binigay na teksto para sa refs na may pangalang cdc-variants); $2
  14. ↑ Deng X, Garcia-Knight MA, Khalid MM, Servellita V, Wang C, Morris MK, atbp. (Marso 2021). "Transmission, infectivity, and antibody neutralization of an emerging SARS-CoV-2 variant in California carrying a L452R spike protein mutation". medRxiv (Preprint). doi:10.1101/2021.03.07.21252647. PMC 7987058. PMID 33758899.{{cite journal}}: CS1 maint: date auto-translated (link)
  15. ↑ Wadman M (2021-02-23). "California coronavirus strain may be more infectious - and lethal". Science News. doi:10.1126/science.abh2101. Nakuha noong 2021-03-17.{{cite news}}: CS1 maint: date auto-translated (link)
  16. ↑ Planas D, Bruel T, Grzelak L, atbp. (2021-04-14). "Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies". Nature Medicine. doi:10.1038/s41591-021-01318-5.{{cite journal}}: CS1 maint: date auto-translated (link)
  17. ↑ "Coronavirus: Sinovac vaccine gives 70 per cent less protection against South African variant, but Hongkongers urged to still get jab". www.scmp.com. 20 Abril 2021. Nakuha noong 20 Abril 2021.{{cite web}}: CS1 maint: date auto-translated (link)
  18. ↑ "PANGO lineages". cov-lineages.org. Inarkibo mula sa orihinal noong 2021-06-03. Nakuha noong 2021-04-17.{{cite web}}: CS1 maint: date auto-translated (link)
  19. ↑ Maling banggit (Hindi tamang <ref> tag; walang binigay na teksto para sa refs na may pangalang IndiaPHE); $2
  20. ↑ Nuki, Paul; Newey, Sarah (2021-04-16). "Arrival of India's 'double mutation' adds to variant woes, but threat posed remains unclear". The Telegraph (sa wikang Ingles). ISSN 0307-1235. Nakuha noong 2021-04-17.{{cite news}}: CS1 maint: date auto-translated (link)
  21. ↑ Yadav PD, Sapkal GN, Abraham P, Ella R, Deshpande G, Patil DY, atbp. (Abril 2021). "Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees". medRxiv (Preprint). doi:10.1101/2021.04.23.441101.{{cite journal}}: CS1 maint: date auto-translated (link)
  22. ↑ Maling banggit (Hindi tamang <ref> tag; walang binigay na teksto para sa refs na may pangalang ImmuneEscape); $2
  23. ↑ "P.1". cov-lineages.org. Pango team. Nakuha noong 2021-03-22.{{cite web}}: CS1 maint: date auto-translated (link)
  24. ↑ Coutinho RM, Marquitti FM, Ferreira LS, Borges ME, da Silva RL, Canton O, atbp. (2021-03-23). "Model-based estimation of transmissibility and reinfection of SARS-CoV-2 P.1 variant". medRxiv (Preprint): 9. doi:10.1101/2021.03.03.21252706. Nakuha noong 2021-04-29. The new variant was found to be about 2.6 times more transmissible (95% Confidence Interval (CI): 2.4–2.8) than previous circulating variant(s). ... Table 1: Summary of the fitted parameters and respective confidence intervals considering the entire period, November 1 2020-January 31, 2021 maintaining the same pathogenicity of the previous variant. Parameter: Relative transmission rate for the new variant. Estimate: 2.61. 2.5%: 2.45. 97.5%: 2.76.{{cite journal}}: CS1 maint: date auto-translated (link)
  25. ↑ 25.0 25.1 Maling banggit (Hindi tamang <ref> tag; walang binigay na teksto para sa refs na may pangalang cadde-p1); $2
  26. ↑ Maling banggit (Hindi tamang <ref> tag; walang binigay na teksto para sa refs na may pangalang UK); $2
  27. ↑ Maling banggit (Hindi tamang <ref> tag; walang binigay na teksto para sa refs na may pangalang Pango B.1.525); $2


Maling banggit (May <ref> tag na ang grupong "note", pero walang nakitang <references group="note"/> tag para rito); $2

Kinuha sa "https://tl.wikipedia.org/w/index.php?title=Mga_baryante_ng_SARS-CoV-2&oldid=2040141"